Pennsylvania has seen improvement over the past five years in the diagnosis rate and survivability of lung cancer, but more can be done. These are among the trends examined in the American Lung ...

Camrelizumab plus chemotherapy doubled the five-year survival rate in advanced squamous lung cancer to 27.8%, reducing mortality risk by 43%. The CameL-sq trial demonstrated camrelizumab's efficacy as ...

Raymond Osarogiagbon, MD, highlights the potential benefits of increasing screening rates for patients diagnosed with lung cancer and the broader US health care system. In part 2 of an interview ...

ATLANTA — A new report from the American Lung Association reveals that Georgia ranks among the worst states in the nation for lung cancer survival rates. The 2025 State of Lung Cancer report, released ...

People from different backgrounds interacting in London. Image by Tim Sandle. People from different backgrounds interacting in London. Image by Tim Sandle. The most comprehensive study yet conducted ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Tuesday announced five-year follow-up results on overall survival (OS) from the Phase 3 EMPOWER-Lung 3 trial of Libtayo (cemiplimab) plus ...

A groundbreaking study has revealed a significant link between the frequency of chest x-ray referrals from GPs and earlier diagnosis and improved survival rates for lung cancer patients. Research from ...

A Birmingham-based doctor has shared the most "unusual" signs of lung cancer, after revealing it has one of the lowest survival rates in Britain. Dr Rupa Parmar, a GP and Medical Director at Midland ...

Wendy Brooks, a patient with extensive-stage small cell lung cancer, and her husband and care partner, Larry Brooks, sat down ...

St Andrew’s nurse Emily Day spent her final months advocating for better lung cancer screening. Now, as her family prepares ...